drugset / Trial / NCT00761592
Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm
RandomizedParallel-groupTriple-blindTreatment
Summary
This pilot study estimates the treatment effects of two different types of botulinum toxin type A in the treatment of Blepharospasm. Blepharospasm is characterised by excessive contraction of the muscles around the eye and can lead to repetitive blinking or sustained closure of the eyelids.
Timeline
- Start
- 2006-07
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 40 iu | — |